(Q41115871)

English

A 12-Month Randomized Controlled Study of the Aldose Reductase Inhibitor Ponalrestat in Patients with Chronic Symptomatic Diabetic Neuropathy

scientific article published on June 1, 1992

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

26 September 2017

A 12-Month Randomized Controlled Study of the Aldose Reductase Inhibitor Ponalrestat in Patients with Chronic Symptomatic Diabetic Neuropathy (English)

1 reference

10.1111/J.1464-5491.1992.TB01818.X

https://api.crossref.org/works/10.1111/J.1464-5491.1992.TB01818.X

15 October 2022

1 reference

10.1111/J.1464-5491.1992.TB01818.X

https://api.crossref.org/works/10.1111/J.1464-5491.1992.TB01818.X

15 October 2022

internal medicine

1 reference

10.1111/J.1464-5491.1992.TB01818.X

https://api.crossref.org/works/10.1111/J.1464-5491.1992.TB01818.X

15 October 2022

author name string

A. J. Krentz

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1611835

15 October 2022

L. Honigsberger

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1611835

15 October 2022

S. H. Ellis

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1611835

15 October 2022

M. Hardman

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1611835

15 October 2022

M. Nattrass

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1611835

15 October 2022

language of work or name

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1611835

15 October 2022

publication date

1 June 1992

1 reference

Europe PubMed Central

26 September 2017

full work available at URL

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1464-5491.1992.tb01818.x

1 reference

10.1111/J.1464-5491.1992.TB01818.X

https://api.crossref.org/works/10.1111/J.1464-5491.1992.TB01818.X

15 October 2022

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1464-5491.1992.tb01818.x/fullpdf

1 reference

10.1111/J.1464-5491.1992.TB01818.X

https://api.crossref.org/works/10.1111/J.1464-5491.1992.TB01818.X

15 October 2022

Diabetic Medicine

1 reference

Europe PubMed Central

26 September 2017

9

1 reference

Europe PubMed Central

26 September 2017

463-468

1 reference

Europe PubMed Central

26 September 2017

5

1 reference

Europe PubMed Central

26 September 2017

Diabetic peripheral neuropathies

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.1992.TB01818.X

21 January 2018

Banting lecture 1986. Does a common mechanism induce the diverse complications of diabetes?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.1992.TB01818.X

21 January 2018

Diabetic neuropathy: clinical aspects

1

1 reference

10.1111/J.1464-5491.1992.TB01818.X

https://api.crossref.org/works/10.1111/J.1464-5491.1992.TB01818.X

15 October 2022

Are disturbances of sorbitol, phosphoinositide, and Na+-K+-ATPase regulation involved in pathogenesis of diabetic neuropathy?

5

1 reference

10.1111/J.1464-5491.1992.TB01818.X

https://api.crossref.org/works/10.1111/J.1464-5491.1992.TB01818.X

15 October 2022

Aldose reductase inhibitors: a potential new class of agents for the pharmacological control of certain diabetic complications

6

1 reference

10.1111/J.1464-5491.1992.TB01818.X

https://api.crossref.org/works/10.1111/J.1464-5491.1992.TB01818.X

15 October 2022

Aldose reductase inhibitors and diabetic complications

7

1 reference

10.1111/J.1464-5491.1992.TB01818.X

https://api.crossref.org/works/10.1111/J.1464-5491.1992.TB01818.X

15 October 2022

Aldose reductase inhibition improves nerve conduction velocity in diabetic patients

9

1 reference

10.1111/J.1464-5491.1992.TB01818.X

https://api.crossref.org/works/10.1111/J.1464-5491.1992.TB01818.X

15 October 2022

A Controlled Trial of Sorbinil, an Aldose Reductase Inhibitor, in Chronic Painful Diabetic Neuropathy

10

1 reference

10.1111/J.1464-5491.1992.TB01818.X

https://api.crossref.org/works/10.1111/J.1464-5491.1992.TB01818.X

15 October 2022

Clinical and neurophysiological studies with the aldose reductase inhibitor, sorbinil, in symptomatic diabetic neuropathy.

11

1 reference

10.1111/J.1464-5491.1992.TB01818.X

https://api.crossref.org/works/10.1111/J.1464-5491.1992.TB01818.X

15 October 2022

Limited benefit of treatment of diabetic polyneuropathy with an aldose reductase inhibitor: a 24-week controlled trial

12

1 reference

10.1111/J.1464-5491.1992.TB01818.X

https://api.crossref.org/works/10.1111/J.1464-5491.1992.TB01818.X

15 October 2022

Regeneration and repair of myelinated fibers in sural-nerve biopsy specimens from patients with diabetic neuropathy treated with sorbinil

13

1 reference

10.1111/J.1464-5491.1992.TB01818.X

https://api.crossref.org/works/10.1111/J.1464-5491.1992.TB01818.X

15 October 2022

A multicentre trial of the aldose-reductase inhibitor, tolrestat, in patients with symptomatic diabetic neuropathy

14

1 reference

10.1111/J.1464-5491.1992.TB01818.X

https://api.crossref.org/works/10.1111/J.1464-5491.1992.TB01818.X

15 October 2022

Clinical and neurophysiological studies of aldose reductase inhibitor ponalrestat in chronic symptomatic diabetic peripheral neuropathy

15

1 reference

10.1111/J.1464-5491.1992.TB01818.X

https://api.crossref.org/works/10.1111/J.1464-5491.1992.TB01818.X

15 October 2022

The natural history of painful diabetic neuropathy--a 4-year study

16

1 reference

10.1111/J.1464-5491.1992.TB01818.X

https://api.crossref.org/works/10.1111/J.1464-5491.1992.TB01818.X

15 October 2022

Selection of patients with symptomatic diabetic neuropathy for clinical trials

17

1 reference

10.1111/J.1464-5491.1992.TB01818.X

https://api.crossref.org/works/10.1111/J.1464-5491.1992.TB01818.X

15 October 2022

Electrophysiological studies in diabetic neuropathy

18

1 reference

10.1111/J.1464-5491.1992.TB01818.X

https://api.crossref.org/works/10.1111/J.1464-5491.1992.TB01818.X

15 October 2022

Use of a biothesiometer to measure individual vibration thresholds and their variation in 519 non-diabetic subjects.

20

1 reference

10.1111/J.1464-5491.1992.TB01818.X

https://api.crossref.org/works/10.1111/J.1464-5491.1992.TB01818.X

15 October 2022

Respiratory influence on heart rate in diabetes mellitus

21

1 reference

10.1111/J.1464-5491.1992.TB01818.X

https://api.crossref.org/works/10.1111/J.1464-5491.1992.TB01818.X

15 October 2022

Meaningful degrees of prevention or improvement of nerve conduction in controlled clinical trials of diabetic neuropathy

22

1 reference

10.1111/J.1464-5491.1992.TB01818.X

https://api.crossref.org/works/10.1111/J.1464-5491.1992.TB01818.X

15 October 2022

A Study of Peripheral Diabetic Neuropathy. The Application of Age-Related Reference Values

24

1 reference

10.1111/J.1464-5491.1992.TB01818.X

https://api.crossref.org/works/10.1111/J.1464-5491.1992.TB01818.X

15 October 2022

Report and recommendations of the San Antonio conference on diabetic neuropathy. Consensus statement

25

1 reference

10.1111/J.1464-5491.1992.TB01818.X

https://api.crossref.org/works/10.1111/J.1464-5491.1992.TB01818.X

15 October 2022

Vibratory and cooling detection thresholds compared with other tests in diagnosing and staging diabetic neuropathy.

26

1 reference

10.1111/J.1464-5491.1992.TB01818.X

https://api.crossref.org/works/10.1111/J.1464-5491.1992.TB01818.X

15 October 2022

Detection, characterization, and staging of polyneuropathy: assessed in diabetics

27

1 reference

10.1111/J.1464-5491.1992.TB01818.X

https://api.crossref.org/works/10.1111/J.1464-5491.1992.TB01818.X

15 October 2022

Capillary number and percentage closed in human diabetic sural nerve

28

1 reference

10.1111/J.1464-5491.1992.TB01818.X

https://api.crossref.org/works/10.1111/J.1464-5491.1992.TB01818.X

15 October 2022

Microangiopathy in human diabetic neuropathy: relationship between capillary abnormalities and the severity of neuropathy

29

1 reference

10.1111/J.1464-5491.1992.TB01818.X

https://api.crossref.org/works/10.1111/J.1464-5491.1992.TB01818.X

15 October 2022

Identifiers

10.1111/J.1464-5491.1992.TB01818.X

1 reference

Europe PubMed Central

26 September 2017

1 reference

Europe PubMed Central

26 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41115871&oldid=1751257621"